Clinical Trials at UPMC Altoona
As of July 2026, 13 paid clinical trials are recruiting at UPMC Altoona, located at 620 HOWARD AVE., ALTOONA, PA 16601-4899, phone (814) 889-2223 in Altoona, Pennsylvania. Active studies at this site cover conditions such as Malignant Female Reproductive System Neoplasm, Recurrent Malignant Female Reproductive System Neoplasm and Recurrent Malignant Solid Neoplasm. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
13 clinical trials at UPMC Altoona
·Clear filters·Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Common conditions studied in Altoona
- Malignant Female Reproductive System Neoplasm (2 active studies)
- Recurrent Malignant Female Reproductive System Neoplasm (2 active studies)
- Recurrent Malignant Solid Neoplasm (2 active studies)
- Stage IV Lung Cancer AJCC v8 (2 active studies)
- Advanced Malignant Solid Neoplasm (1 active study)
- Anatomic Stage III Breast Cancer AJCC v8 (1 active study)
Leading research sponsors in Altoona
- National Cancer Institute (NCI)
- NRG Oncology
- SWOG Cancer Research Network
- ECOG-ACRIN Cancer Research Group
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Altoona?
There are approximately 19 recruiting clinical trials in Altoona, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Altoona pay participants?
Most recruiting trials in Altoona compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Altoona?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Altoona?
The most common conditions under active study in Altoona include Malignant Female Reproductive System Neoplasm (2), Recurrent Malignant Female Reproductive System Neoplasm (2), Recurrent Malignant Solid Neoplasm (2), Stage IV Lung Cancer AJCC v8 (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Altoona?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Altoona on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Altoona?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Altoona?
Recruiting research sites in Altoona include UPMC Altoona, University Orthopedics Center, Allegheny Surgery Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Altoona right now?
The largest active categories in Altoona are Cancer & tumors (13), Neurology & pain (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of UPMC Altoona?
UPMC Altoona is located at 620 HOWARD AVE., ALTOONA, PA 16601-4899. Use the Google Maps link in the intro above to get directions.
How do I contact UPMC Altoona?
You can reach UPMC Altoona by phone at (814) 889-2223. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.